Gyanson Zones Medical And Scientific Publishers Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 8 Year, 5 Months
- Last Filing with ROC 31 Mar 2020
- Revenue Growth %
- Profit Growth -7.50%
- Ebitda -20.00%
- Net Worth -10.24%
- Total Assets -9.66%
About Gyanson Zones Medical And Scientific Publishers
Gyanson Zones Medical And Scientific Publishers Private Limited (GZMASPPL) is a Private Limited Indian Non-Government Company incorporated in India on 06 September 2016 (Eight years and five months 16 days old ). Its registered office is in Delhi, India.
The Company is engaged in the Printing & Publishing Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2020. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Gaurav Singh and Vishram Singh serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U22219DL2016PTC305486
- Company No.
305486
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Sep 2016
- Date of AGM
31 Dec 2020
- Date of Balance Sheet
31 Mar 2020
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Gyanson Zones Medical And Scientific Publishers?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vishram Singh  | Director | 06-Sep-2016 | Current |
| Gaurav Singh | Director | 06-Sep-2016 | Current |
Financial Performance of Gyanson Zones Medical And Scientific Publishers.
Gyanson Zones Medical And Scientific Publishers Private Limited, for the financial year ended 2019, experienced no change in revenue, with a 0% increase. The company also saw a slight decrease in profitability, with a 7.5% decrease in profit. The company's net worth observed a substantial decline by a decrease of 10.24%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Gyanson Zones Medical And Scientific Publishers?
Unlock access to Gyanson Zones Medical And Scientific Publishers's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Gyanson Zones Medical And Scientific Publishers?
Unlock and access historical data on people associated with Gyanson Zones Medical And Scientific Publishers, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Gyanson Zones Medical And Scientific Publishers, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gyanson Zones Medical And Scientific Publishers's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.